Lymphoma & Plasma Cell Disorders
From the Journals
Autotransplant is linked to higher AML, MDS risk
For patients with lymphoma or plasma cell myeloma, autologous hematopoietic cell transplantation was linked to marked increases in the risk of AML...
News
Team recommends melanoma screening in CLL
Patients with chronic lymphocytic leukemia (CLL) should be routinely monitored for melanoma, according to researchers. A study of 470 CLL patients...
News
Janssen seeks approval for split dosing of daratumumab
Safety and pharmacokinetics concentrations were comparable regardless of split or single dosing of daratumumab.
News
Frequent BCCs linked to blood cancers
New research suggests people who develop frequent cases of basal cell carcinoma (BCC) have an increased risk of leukemias, lymphomas, and other...
Latest News
Increased B-cell lymphoma risk with JAK1/2 inhibitors
There may be an opportunity to determine which patients are at risk.
News
FDA approves mogamulizumab for MF, SS
The US Food and Drug Administration (FDA) has approved mogamulizumab-kpkc (Poteligeo®) for the treatment of adults with relapsed or refractory...
News
Treatment guidelines for CAR T-cell therapy
Researchers have developed treatment guidelines for pediatric patients receiving chimeric antigen receptor (CAR) T-cell therapy. The guidelines...
From the Journals
Insurance is a matter of life or death for lymphoma patients
Improving patient access to affordable private insurance could improve survival outcomes for patients with follicular lymphoma.
News
Company narrows focus of development for tazemetostat
Epizyme, Inc., has announced its decision to stop developing tazemetostat for use as monotherapy or in combination with prednisolone for patients...
From the Journals
PET/CT accurately predicts MCL stage
The promising results suggest bone marrow involvement could be assessed without a biopsy.